Robert A. Zivin
- Genetics top 2%
- Immunology top 5%
- Molecular Biology top 10%
- Surgery top 5%
- Endocrinology, Diabetes and Metabolism top 2%
- Co-authors
- Jeffrey A. BluestoneDanlin XuJulie AugerLinda K. JolliffeDavid DonaldsonKevan C. HeroldLesley TaylorDavid M. Harlan
- Topics
- Monoclonal and Polyclonal Antibodies Research (9 papers)T-cell and B-cell Immunology (5 papers)Immunotherapy and Immune Responses (4 papers)
- Partner nations
- United StatesJapanNorway
In The Last Decade
Robert A. Zivin
31 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Genetics 1.1k
- Immunology 846
- Molecular Biology 759
- Surgery 743
- Endocrinology, Diabetes and Metabolism 665
Countries citing papers authored by Robert A. Zivin
This map shows the geographic impact of Robert A. Zivin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Zivin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Zivin more than expected).
Fields of papers citing papers by Robert A. Zivin
This network shows the impact of papers produced by Robert A. Zivin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Zivin. The network helps show where Robert A. Zivin may publish in the future.
Co-authorship network of co-authors of Robert A. Zivin
This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Zivin. A scholar is included among the top collaborators of Robert A. Zivin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Zivin. Robert A. Zivin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 12 | |
| 3 | 48 | |
| 4 | 46 | |
| 5 | Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial. | 98 |
| 6 | Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitusbreakdown → | 903 |
| 7 | 94 | |
| 8 | 50 | |
| 9 | 24 | |
| 10 | 13 | |
| 11 | Cytochrome P450 induction in rat hepatocytes assessed by quantitative real-time reverse-transcription polymerase chain reaction and the RNA invasive cleavage assay. | 27 |
| 12 | 177 | |
| 13 | 140 | |
| 14 | Phase I evaluation of humanized OKT3: toxicity and immunomodulatory effects of hOKT3gamma4. | 35 |
| 15 | 30 | |
| 16 | 46 | |
| 17 | 3 | |
| 18 | 52 | |
| 19 | 61 | |
| 20 | 22 |
About Robert A. Zivin
Robert A. Zivin is a scholar working on Transplantation, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 31 papers that have together received 2.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), T-cell and B-cell Immunology (5 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Immunology (846 citations), Endocrinology, Diabetes and Metabolism (665 citations) and Genetics (1.1k citations). Robert A. Zivin has collaborated with scholars based in United States, Japan and Norway. Frequent co-authors include Jeffrey A. Bluestone, Danlin Xu, Julie Auger, Linda K. Jolliffe, David Donaldson, Kevan C. Herold, Lesley Taylor, David M. Harlan, William Hagopian and Stephen E. Gitelman. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.